Chapter 17 High Risk Neonates Flashcards
Incident decreases with increasing gestational age; affects 10% of all preterms (<28wks)
Respiratory distresssyndrome (RDS)
Results from underdeveloped and small alveoli and insufficient levels of surfactant
Respiratory distress syndrome (RDS)
Composed of 90% phospholipids and 10% protein
Pulmonary surfactant
Type II Alveolar cells
Located with in the lungs; produced pulmonary surfactant (starting at 24 to 28 weeks)
To test used to evaluate fetal lung maturity
PG
L/S ratio
PDA Pneumothorax Bronchopulmonary hypertension Pulmonary edema Hypotension Anemia, oliguria, hypo glycemia Altered calcium and sodium levels Retinopathy of prematurity Seizures Intraventricular hemorrhage
Complications of RDS
progressively harder to breath; tachypnea;
respiratory Triad: (retractions, expiratory grunting, nasal flaring)
S/S of Rds
X-ray RDS
Reticulogranular pattern of the peripheral long fields and air bronchograms
Treatment of RDS
Exaggerates surfactant
CPAP
High frequency oscillatory ventilation
ECMO
X-ray yields Groundglass appearance
Progresses to gray out
RDS
Laboratory test nonspecific